Immunovantinc Stock Widgets and Gadgets
| IMVT Stock | USD 28.43 1.97 6.48% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- IMVT ImmunovantInc
- Latest What Makes Immunovant a New Buy Stock
- IMVT 28.43 -1.97
- Low 28.23
- High 30.35
- Alpha -0.62
- Beta 0.81
- Return On Equity -0.45
- Return On Asset -0.27
- Current Valuation 3.73 B
- Shares Outstanding 145.29 M
- Shares Owned By Insiders 55.55 %
- Shares Owned By Institutions 47.60 %
- Number Of Shares Shorted 9.02 M
- Price To Book 6.28 X
- EBITDA (198.28 M)
- Net Income (210.96 M)
- Cash And Equivalents 427.2 M
- Cash Per Share 3.66 X
- Total Debt 1.22 M
- Debt To Equity 0 %
- Current Ratio 21.48 X
- Book Value Per Share 4.68 X
- Cash Flow From Operations (188.19 M)
- Short Ratio 6.97 X
- Earnings Per Share (1.81) X
- Target Price 50.67
- Number Of Employees 164
- Beta 0.7
- Market Capitalization 4.42 B
- Total Asset 405.84 M
- Retained Earnings (566.35 M)
- Working Capital 361.04 M
- Net Asset 405.84 M
- Accumulation Distribution 0.0699
- Daily Balance Of Power (0.93)
- Rate Of Daily Change 0.94
- Day Median Price 29.29
- Day Typical Price 29.0
- Market Facilitation Index 2.12
- Price Action Indicator (1.85)
- Period Momentum Indicator (1.97)
- Relative Strength Index 54.26
Market Snapshot Widget Example
DAX Index Germany | 17,837 0.38 | |
Taiwan Weighted Taiwan | 20,301 0.43 | |
PSI 20 Stock Portugal | 6,328 1.50 | |
CROBEX Croatia | 2,803 0.35 | |
Budapest SE Hungary | 65,674 0.67 | |
IDX 30 Jakarta Indonesia | 474.44 0.75 | |
ISEQ 20 Price Ireland | 1,628 0.48 | |
NYSE Comp USA | 17,388 0.09 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,030 0.88 | |
IPC MEXICO Mexico | 55,739 0.11 | |
KL Technology Malaysia | 63.89 0.14 | |
IBEX 35 Index Spain | 10,765 1.23 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,538 0.87 | |
SPASX Dividend Opportunities Australia | 1,661 0.59 | |
HNX 30 Vietnam | 484.87 2.28 | |
Bucharest BET-NG Romania | 1,207 0.53 | |
AMS Small Cap Netherlands | 1,208 0.74 | |
Oslo Exchange Mutual Norway | 1,291 0.38 | |
BEL Small Belgium | 8,962 0.02 | |
RTSI Index Russia | 1,160 0.54 | |
Basic Materials Brazil | 5,868 0.0041 | |
Swiss Leader Price Switzerland | 1,837 0.12 | |
Fondo Mutuo ETF Chile | 1,428 0.94 | |
Athens General Comp Greece | 1,381 1.14 | |
Stock Exchange Of Thailand | 1,361 0.43 | |
PX Prague Stock Czech Repub | 1,548 0.04 | |
THE PHILIPPINE STOCK Philippines | 6,523 1.13 | |
WIG 30 Poland | 3,051 1.24 | |
BIST Electricity Turkey | 583.83 0.78 |
Investing Ideas
In addition to having ImmunovantInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare ImmunovantInc
Compare ImmunovantInc To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for ImmunovantInc Stock analysis
When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.